Drugmaker Hikma`s U.S. unit raises medicine prices: Financial Times

Published 9y ago

Hikma Pharmaceuticals Plc's U.S. subsidiary has raised the price of a common diarrhea drug by more than 400 percent and is charging more for five other medicines as well, the Financial Times reported on Sunday. More »